Skip to main content

Published locations for DECIDE: Daclizumab cuts MS relapse rate by 45%

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. DECIDE: Daclizumab cuts MS relapse rate by 45%

User login

  • Reset your password
  • /content/decide-daclizumab-cuts-ms-relapse-rate-45
  • /familypracticenews/article/98965/multiple-sclerosis/decide-daclizumab-cuts-ms-relapse-rate-45
  • /internalmedicinenews/article/98965/multiple-sclerosis/decide-daclizumab-cuts-ms-relapse-rate-45
  • /internalmedicine/article/98965/multiple-sclerosis/decide-daclizumab-cuts-ms-relapse-rate-45
  • /neurology/article/98965/multiple-sclerosis/decide-daclizumab-cuts-ms-relapse-rate-45
  • /familymedicine/article/98965/multiple-sclerosis/decide-daclizumab-cuts-ms-relapse-rate-45
  • /clinicalneurologynews/article/98965/multiple-sclerosis/decide-daclizumab-cuts-ms-relapse-rate-45